Where does Bittium Biosignals Oy rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bittium Biosignals Oy ranks #18,442 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bittium Biosignals Oy hold?

Bittium Biosignals Oy holds 15 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Bittium Biosignals Oy's Innovation Score?

Bittium Biosignals Oy has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bittium Biosignals Oy focus on?

Bittium Biosignals Oy's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 15 patents, ranking #1,165 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Bittium Biosignals Oy's patent grant rate increasing or decreasing?

Bittium Biosignals Oy's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bittium Biosignals Oy's patents?

Bittium Biosignals Oy's patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bittium Biosignals Oy patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bittium Biosignals Oy

USPTO PatentsView assignee record - 15 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bittium ranks #18,442 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 4 technology areas.

#18,442
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 13.9
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18442 · Foreign Corporation #18,442 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,442/49,997
PHOTO-FINISH BioApplications
CPC-NARROW A61B · 4 areas
INNOV-PAR 42.8/100
CLAIMS-RICH 13.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: BioApplications Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bittium’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (22%) Velocity 17.8 pts (41%) Breadth 7.1 pts (17%) Claim depth 8.4 pts (20%)

Qualcomm Incorporated · highest

85
Bittium Biosignals Oy · this assignee

43
3D Lighting… · lowest

7

What this shows Bittium's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bittium?

Each dot is one of Bittium’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bittium’s own 13.9 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bittium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bittium's grants concentrate

Bittium Biosignals Oy is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2017. By volume, Bittium sits between BioApplications Inc. and Bright Machines, Inc..

Bittium's three-year grant acceleration

Bittium Biosignals Oy shows 8 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bioapplications

15
Biolite

15
Biological E

15
Bitstrata Systems

15
Bluefin Biomedici…

15
Bottlekeeper

15
Brane Audio

15
Bright Machines

15
Bittium Biosignal… ◀

15

What this shows Bittium holds 15 patents at rank #18,451, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bittium

By rank, the assignees closest to #18,451 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bittium's primary technology class.

Bittium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Bittium Biosignals Oy patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	6.7%
2019	1	6.7%
2021	2	13.3%
2022	3	20.0%
2023	4	26.7%
2024	1	6.7%
2025partial year	3	20.0%

Which technologies does Bittium Biosignals Oy patent most?

A61B - DIAGNOSIS; SURGERY; Identification 15

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 5

G06F - Electric Digital Data Processing 2

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bittium Biosignals Oy's patent record in context - here's where to go next.

Bittium Biosignals Oy's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #18,442 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bittium Biosignals Oy against BioApplications Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.